EYPT
EyePoint Pharmaceuticals (EYPT)
$
33About EyePoint Pharmaceuticals (EYPT)
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Details
Daily high
$6.66
Daily low
$6.32
Price at open
$6.34
52 Week High
$29.44
52 Week Low
$5.90
Market cap
430.7M
Dividend yield
0.00%
Volume
174,664
Avg. volume
862,641
P/E ratio
-3.14
EyePoint Pharmaceuticals News
Details
Daily high
$6.66
Daily low
$6.32
Price at open
$6.34
52 Week High
$29.44
52 Week Low
$5.90
Market cap
430.7M
Dividend yield
0.00%
Volume
174,664
Avg. volume
862,641
P/E ratio
-3.14